Yun-Feng Cheng
Overview
Explore the profile of Yun-Feng Cheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
517
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu F, An Z, Cui L, Xiao M, Wu Y, Li W, et al.
Adv Sci (Weinh)
. 2025 Mar;
:e2410417.
PMID: 40040609
Corticosteroids (CSs) are the initial therapy for immune thrombocytopenia (ITP); however, their efficacy is not adequately predicted. As a novel biomarker, the composition of the gut microbiota is non-invasively tested...
2.
An Z, Wu Y, Hou Y, Mei H, Nong W, Li W, et al.
Sci Bull (Beijing)
. 2023 Aug;
68(18):2106-2114.
PMID: 37599175
Rare but critical bleeding events in primary immune thrombocytopenia (ITP) present life-threatening complications in patients with ITP, which severely affect their prognosis, quality of life, and treatment decisions. Although several...
3.
Gui R, Huang Q, Cai X, Wu J, Liu H, Liu Y, et al.
Br J Haematol
. 2020 May;
191(2):269-281.
PMID: 32452543
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare and life-threatening haematological emergency. Although therapeutic plasma exchange together with corticosteroids achieve successful outcomes, a considerable number of patients remain refractory to...
4.
Lin Y, Hsieh M, Wang W, Lin Y, Chang W, Chang C, et al.
Radiother Oncol
. 2018 May;
128(3):575-583.
PMID: 29801723
Background: Prospective randomized trials have not been used to evaluate the efficacy of adjuvant therapies after intrahepatic cholangiocarcinoma (ICC) resection. Methods: We analyzed data from the Taiwan Cancer Registry database...
5.
Liu X, Bai X, Chen F, Cheng Y, Dai K, Fang M, et al.
Int J Hematol
. 2018 Apr;
107(6):615-623.
PMID: 29619624
Primary immune thrombocytopenia (ITP) is a bleeding disorder commonly encountered in clinical practice. The International Working Group (IWG) on ITP has published several landmark papers on terminology, definitions, outcome criteria,...
6.
Cai X, Ni X, Yi Y, He H, Wang J, Fu Y, et al.
Medicine (Baltimore)
. 2016 Oct;
95(40):e4989.
PMID: 27749555
Nucleoside triphosphate diphosphohydrolase-1 (ENTPD1/CD39) is the rate-limiting enzyme in a cascade leading to the generation of immunosuppressive adenosine and plays an important role in tumor progression. This study aimed to...
7.
Ni X, Yi Y, Fu Y, He H, Cai X, Wang J, et al.
Medicine (Baltimore)
. 2015 Sep;
94(36):e1486.
PMID: 26356714
There is increasing and consistent evidence concerning the association of systemic inflammation and poor outcome in patients with hepatocellular carcinoma (HCC). The aim of this study was to identify a...
8.
Wang J, Yi Y, Li Y, Cai X, He H, Ni X, et al.
BMC Cancer
. 2014 Apr;
14:297.
PMID: 24774224
Background: Sirtuin 3 (Sirt3), one of the seven Sirtuins family members, plays critical roles in the progression of multiple cancer types. However, its role in the prognosis of hepatocellular carcinoma...
9.
Cai X, Wang J, Yi Y, He H, Ni X, Zhou J, et al.
Asian Pac J Cancer Prev
. 2014 Feb;
15(2):775-80.
PMID: 24568494
Objectives: TCR- gamma-delta + T cells (γδ T cells) are non-conventional T lymphocytes that can recognize and eradicate tumor cells. Our previous studies showed that infiltration and function of γδT...
10.
Gu S, Zhuang J, Zou S, Li F, Wang Z, Cheng Y, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2013 Nov;
34(10):883-6.
PMID: 24171964
Objective: To evaluate the efficacy and safety of recombinant human thrombopoietin (rhTPO) combined with glucocorticoid in treatment of severe newly diagnosed primary immune thrombocytopenia (ITP). Methods: From June 2009 to...